Ed Silverman has done an interesting interview with the maraviroc whistleblower, on the same day the HIV drug maraviroc was suddenly approved.
You can find the interview here: Pfizer Whistleblower Discusses The Aftermath
The approval of maraviroc comes only a couple of days after Pfizer allegedly terminated three senior executives in the HIV divison, among them the sales director.
Timing is interesting . . . and the question could be posed: Did Pfizer gain approval for maraviroc in return for terminating certain individuals?
More on BranweekNRX.
No comments:
Post a Comment